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Abstract
Neuroligin 2 is a postsynaptic protein that plays a critical role in the maturation and proper function of GABAergic synapses.
Previous studies demonstrated that deletion of neuroligin 2 impaired GABAergic synaptic transmission, whereas its
overexpression caused increased inhibition, which suggest that its presence strongly influences synaptic function.
Interestingly, the overexpressing transgenic mouse line showed increased anxiety-like behavior and other behavioral
phenotypes, not easily explained by an otherwise strengthened GABAergic transmission. This suggested that other, non-
GABAergic synapses may also express neuroligin 2. Here, we tested the presence of neuroligin 2 at synapses established by
cholinergic neurons in the mouse brain using serial electron microscopic sections double labeled for neuroligin 2 and
choline acetyltransferase. We found that besides GABAergic synapses, neuroligin 2 is also present in the postsynaptic
membrane of cholinergic synapses in all investigated brain areas (including dorsal hippocampus, somatosensory and medial
prefrontal cortices, caudate putamen, basolateral amygdala, centrolateral thalamic nucleus, medial septum, vertical- and
horizontal limbs of the diagonal band of Broca, substantia innominata and ventral pallidum). In the hippocampus, the
density of neuroligin 2 labeling was similar in GABAergic and cholinergic synapses. Moreover, several cholinergic contact
sites that were strongly labeled with neuroligin 2 did not resemble typical synapses, suggesting that cholinergic axons form
more synaptic connections than it was recognized previously. We showed that cholinergic cells themselves also express
neuroligin 2 in a subset of their input synapses. These data indicate that mutations in human neuroligin 2 gene and genetic
manipulations of neuroligin 2 levels in rodents will potentially cause alterations in the cholinergic system as well, which may
also have a profound effect on the functional properties of brain circuits and behavior.
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Introduction
Neuroligins (NLGNs) are a family of postsynaptic transmem-
brane proteins that bind to presynaptic neurexins [1], whereby
they form a trans-synaptic signal transduction complex and
mediate a bidirectional signaling between the presynaptic axon
and the postsynaptic target [2]. Both NLGNs and neurexins
recruit proteins that are involved in synaptic communication and
are able to induce pre- or postsynaptic specializations [3–5].
Experiments with NLGN-knockout (KO) mice demonstrated that
NLGNs play an important role in the maturation and proper
function of synapses [6,7] and appear to be dynamically regulated
and therefore contribute to the activity dependent stabilization/
destabilization of synapses [8–11].
Four neuroligin isoforms (NLGN1-4) were described in rodent
brain, which were shown to localize to different synapse types.
NLGN1 is present in glutamatergic synapses [12], whereas
NLGN2 was localized to GABAergic and a small subset of
glycinergic synapses [4,13,14]. NLGN3 was found in undefined
subgroups of both glutamatergic and GABAergic synaptic contacts
[15]; whereas NLGN4 was detected in glycinergic synapses [16].
Consistent with the location of different isoforms, manipulation
(deletion or overexpression) of NLGN1 or NLGN2 resulted in
alterations in glutamatergic or GABAergic transmission, respec-
tively [17]. The distinct localization of these NLGN isoforms
suggests that they fulfill different roles in distinct synapse types and
may recruit different kinds of synaptic proteins.
NLGN2 was detected exclusively in inhibitory synapses so far
[4,13,14] and it is of particular interest, because mutations in
human NLGN2 gene were implicated in schizophrenia [18],
whereas manipulations of mouse NLGN2 levels resulted in
characteristic behavioral phenotypes, including an increase in
anxiety levels both in NLGN2-KO and NLGN2-overexpressing
mice [19–21]. Consistent with the location of NLGN2 in
inhibitory synapses, NLGN2-KO mice had impairments in
inhibitory synaptic transmission [20,22–24], whereas NLGN2-
overexpressing animals revealed an increase in inhibition [19].
Interestingly, despite the opposite changes in the strength of
GABAergic transmission detected in NLGN2-KO and NLGN2-
overexpressing mice, both mice showed increased anxiety-like
behavior [19,20]. This enhancement is surprising in case of
NLGN2-overexpressing mouse (where the GABAergic transmis-
sion is enhanced), because positive modulation of GABAergic
signaling (for example benzodiazepine treatment) generally results
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in anxiolytic effects [25]. Some other behavioral and physiological
effects of NLGN2-overexpression are also inconsistent with the
strengthened GABAergic transmission (high level of basal activity,
enhanced startle response, stereotyped jumping behavior and
seizures in frontoparietal EEG [19]). These controversial results
raise the possibility that besides GABAergic synapses, NLGN2 is
expressed in other kinds of synapses as well. To the best of our
knowledge, colocalization of NLGN2 was investigated only with
glutamatergic, GABAergic and glycinergic markers, while synap-
ses that use other types of neurotransmitters were not analyzed
previously. One of the most abundant terminal type of the
mammalian brain is cholinergic, and they provide a massive
innervation in most brain regions [26]. They were shown to
modulate almost every process in the central nervous system
including development, arousal, consciousness, attention, learning
and memory, anxiety and depression [27] and interestingly, in line
with our hypothesis, in human, nicotine dependence was
associated with neurexin-1 gene (which is one of the main binding
partners of NLGNs) [28,29].
Therefore, we tested the presence of NLGN2 in cholinergic
synapses of the mouse brain using serial electron microscopic
sections double labeled for NLGN2 and choline acetyltransferase
(ChAT), the synthesizing enzyme of acetylcholine in axon
terminals. We found that NLGN2 is expressed postsynaptically
at these synapses in all investigated brain areas, and for instance in
the hippocampus, its density was similar to that of the GABAergic
synapses. Moreover, we also found that NLGN2 was present in
atypical contact sites of cholinergic axons that probably would not
have been considered contact site before, suggesting that these
terminals establish more synapses than it was recognized
previously. In addition, we found that cholinergic cells themselves
also express NLGN2 in some of their input synapses. These results
provide the basis for new interpretations of data in the literature,




All experiments were performed in accordance with the
Institutional Ethical Codex and the Hungarian Act of Animal
Care and Experimentation guidelines, which are in concert with
the European Communities Council Directive of November 24,
1986 (86/609/EEC). The Animal Care and Experimentation
Committee of the Institute of Experimental Medicine of Hungar-
ian Academy of Sciences and the Animal Health and Food
Control Station, Budapest, have specifically approved the exper-
imental design under the number of 22.1/362/3/2011.
Tissue preparation
Five male wild-type (WT) C57BL/6J mice (24–60 days old) and
two neuroligin 2 knockout mice (NLGN2-KO; 49 and 67 days old)
[6] were sacrificed. For perfusion, mice were anaesthetized with
isoflurane followed by an intraperitoneal injection of an anesthetic
mixture (containing 0.83% ketamine, 0.17% xylazin hydrochlo-
ride, 0.083% promethazinium chloride, 0.00083% benzethonium
chloride, and 0.00067% hydrochinonum) to achieve deep
anesthesia.
Mice were perfused transcardially with 0.9% NaCl solution for
2 min followed by a fixative containing 4% paraformaldehyde in
0.1 M phosphate buffer (PB, pH 7.4) for 35 min. In case of one
WT mouse the fixative also contained 0.5% glutaraldehyde. The
perfusion with fixative was followed by perfusion with PB for 10
min. The brains were then removed from the skull and coronal
sections were cut on a Leica VT1200S vibratome at 50 or 60 mm.
The sections were rinsed in PB, cryoprotected sequentially in 10%
and 30% sucrose dissolved in PB, freezed over liquid nitrogen and
stored at –70C until further processing.
Immunohistochemistry
Sections were freeze-thawed two times over liquid nitrogen in
30% sucrose dissolved in PB. After extensive washes in PB and
0.05 M Tris-buffered saline (TBS, pH 7.4) endogenous peroxidase-
like activity was blocked by incubation of the sections in 1%
hydrogen peroxide in TBS for 10 min. After repeated washes in
TBS, sections were blocked in 1% human serum albumin (HSA,
Sigma-Aldrich, in TBS) for 1 h. This was followed by a 2–3 days
of incubation in a mixture of primary antibodies for choline
acetyltransferase (ChAT; monoclonal mouse antibody, 1:750) [30]
and for neuroligin 2 (NLGN2; polyclonal rabbit antibody,
Synaptic Systems, Cat. No.: 129 203; Lot No. 10: 1:600, Lot
No. 12–13: 1:300) made up in TBS containing 0.05% sodium
azide. After extensive washes in TBS, sections were treated with
blocking solution (Gel-BS) containing 0.2% cold water fish skin
gelatin and 0.5% HSA in TBS for 1 h. This was followed by an
overnight incubation in a mixture of biotinylated donkey anti-
mouse antibodies (1:1000, Jackson ImmunoResearch Europe Ltd)
and 1.4-nm gold-conjugated goat anti-rabbit antibodies (1:100–
300; Fab’ fragment, Nanoprobes) diluted in Gel-BS. After
repeated washes in TBS and PB, sections were treated with 2%
glutaraldehyde in PB for 15 min to fix the gold particles into the
tissue. This was followed by washes in PB, TBS, and a 2–3 hours
of incubation in Elite ABC (1:300, Vector Laboratories) diluted in
TBS. After sections were washed in TBS and tris-buffer (pH 7.6)
the immunoperoxidase reaction was developed using 3,3-diami-
nobenzidine (DAB) as chromogen. After repeated washes in PB
and Enhancement Conditioning Solution (Aurion), gold particles
were intensified using the Aurion R-Gent Silver Enhancement
Solution (SE-EM) as described by the manufacturer. After
subsequent washes in PB, sections were treated with 0.5% osmium
tetroxide in PB for 8–15 min on ice, dehydrated in ascending
ethanol series and acetonitrile and embedded in epoxy resin
(Durcupan, ACM, Fluka). During dehydration sections were
treated with 1% uranyl acetate in 70% ethanol for 20 min.
Electron microscopy
For electron-microscopic analysis of cholinergic terminals, resin-
embedded tissue samples from the CA1 area of the dorsal
hippocampus, caudate putamen (CPu), basolateral amygdala
(BLA), centrolateral thalamic nucleus (CL), somatosensory (S1)
and medial prefrontal cortices (PFC) were glued onto small
Durcupan blocks. Series of consecutive ultrathin sections (70 nm
thick, at least 14 sections/series) were cut using an ultramicrotome
(Leica EM UC6) and picked up on Formvar-coated single-slot
grids. Ultrathin sections were counterstained with lead citrate
(Ultrostain 2, Leica) and examined in a Hitachi 7100 electron
microscope equipped with a Veleta CCD camera (Olympus Soft
Imaging Solutions, Germany). For evaluation of the NLGN2
content at synapses of ChAT-positive terminals, sections were
systemically scanned for synapses of DAB-labeled ChAT-positive
boutons. Parallel appositions between the membranes of the
presynaptic bouton and the putative postsynaptic target were
regarded as synapses if they displayed widening of the extracellular
space at the presumptive synaptic cleft, a postsynaptic membrane
thickening, and clustered synaptic vesicles in the bouton. Synapses
found were followed and photographed at 30,000 magnification in
every section where they were present throughout the series: thus
these synapses were fully reconstructed. For the semiquantitative
Neuroligin 2 Is Localized at Cholinergic Synapses
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analyses, we measured the length of synapses from these series of
digital images using the ImageJ image analyzer software (NIH,
USA) then counted the immunogold particles at the postsynaptic
membrane. Gold particles were considered to be associated with
the cell membrane only when they were not farther away from the
membrane than 40 nm. The density of immunogold particles at
extrasynaptic plasma membranes and type I synaptic membranes
of the target profiles was also measured.
For comparison of NLGN2 contents of ChAT-positive and
GABAergic terminals in the hippocampus, we have also
measured the immunogold densities of partially or fully
reconstructed somatic synapses in the pyramidal layer of the
hippocampal CA1 area, because hippocampal pyramidal cells
receive only GABAergic synapses onto their somata in rodents
[31]. These synapses were reconstructed from the very same
series of sections.
Postsynaptic targets of hippocampal cholinergic terminals were
classified as described earlier [32]. Briefly, spines were recognized
by their small size and specific morphology. Dendrites that have
spines and do not receive type I (asymmetric) inputs on their
shafts are known to be pyramidal cells [31], whereas dendrites
receiving type I synapses on their shafts are interneurons [33].
The robustness of this classification method was reconfirmed
recently [32]. Cell bodies from str. pyramidale that did not
receive type I inputs were considered to be pyramidal cells,
whereas cell bodies in other layers were classified as interneurons.
In other brain areas (see above) only the dendrites and spines
were discriminated.
For electron microscopic analysis of input synapses of cholin-
ergic cells, tissue samples were taken from medial septum (MS),
vertical- and horizontal limbs of the diagonal band of Broca (VDB
and HDB), substantia innominata/ventral pallidum (SI/VP) and
CPu. Consecutive series of ultrathin sections were systematically
scanned for NLGN2-positive synapses of DAB-labeled ChAT-
positive dendrites and somata. MS, VDB, HDB and SI/VP were
also scanned for NLGN2-positive synapses of ChAT-positive
terminals.
Specificity of antibodies
We tested the NLGN2 antibody in experiments with NLGN2-
KO mice (n = 2). At the electron microscopic level, specific
labeling of synapses could not be detected in these animals (Fig. 1B
and C). We have also investigated 28 completely reconstructed
synapses of hippocampal ChAT-positive terminals from two
NLGN2-KO mice and found only one gold particle in only one
synapse. Therefore, the density of synaptic labeling in WT animals
was 240-fold larger than in NLGN2-KO mice (9.666.02 vs.
0.0460.24 intensified gold particles/ mm) demonstrating that the
background labeling is negligible. The ChAT antibody was used in
several previous studies [34–39], and its specificity has been
characterized previously [30].
Statistical Analysis
A statistical analysis was carried out using the software Statistica
(StatSoft). When data populations had a Gaussian distribution
according to the Shapiro-Wilk’s W test, we reported parametric
statistical features (mean 6 SD). In the case of non-Gaussian
distribution, we used non-parametric statistical features (median,
interquartile ranges). Two groups showing Gaussian distribution
were compared using the parametric t test. The Kruskal-Wallis
test was used to compare the data from three groups showing non-
Gaussian distribution. The differences were considered significant
at p, 0.05.
Results
Neuroligin 2 is abundant at hippocampal cholinergic
synapses
Although NLGN2 is widely considered to be present only in
GABAergic synapses [2,7,40–44], we tested its presence at
cholinergic synapses as well. We performed double immunogold/
immunoperoxidase labeling for NLGN2 and choline acetyltrans-
ferase (ChAT), the synthesizing enzyme of acetylcholine. In the
hippocampus of NLGN2-KO mice, no specific NLGN2 labeling
was found (see Methods, Fig. 1B and C). First, we tested the
presence of NLGN2 in GABAergic synapses. CA1 pyramidal cells
were shown to receive exclusively GABAergic synapses onto their
somata in rodents [31], therefore these synapses were considered
to be GABAergic. We confirmed the presence of NLGN2 in these
type II (symmetric) synapses of GABAergic boutons (Fig. 1A)
[13,45].
Interestingly, synapses of ChAT-positive terminals were also
densely labeled at the postsynaptic membrane (Fig. 1D–G). To
estimate and compare the abundance of NLGN2 in cholinergic
and GABAergic synapses we tested fully reconstructed synapses of
ChAT-positive terminals from str. radiatum (n = 59), pyramidale
(n = 13) and oriens (n = 35) and fully or partially reconstructed
synapses of GABAergic somatic boutons (n = 69) on pyramidal cell
bodies in the CA1 area of three mice. Hippocampal cholinergic
boutons formed type II synapses that were usually very small (they
were present typically only in 2–4 (2.961.2) 70 nm-thick sections,
median of synaptic membrane area: 0.0256 mm2, interquartile
range: 0.0205–0.0369 mm2; n = 107, three mice, pooled, Fig. 1D–
I) compared to GABAergic synapses. For example, the size of
parvalbumin and cannabinoid receptor 1 positive somatic
synapses per contact are about 0.07 and 0.22 mm2, respectively
(our unpublished observations). Please note, that although
synapses were collected in a random fashion, these are only
semiquantitative measurements, nevertheless they still clearly
demonstrate the tendency that cholinergic synapses are smaller
than GABAergic ones.
In three WT mice, 100%; 100% and 95.8% of the GABAergic
synaptic connections (n = 68 out of 69) and 94.3%; 97.1% and
86.5% of cholinergic synapses (n = 99 out of 107) were identified as
NLGN2 positive on the basis of intensified immunogold particles
associated with the postsynaptic membrane. The somewhat lower
positivity of the cholinergic synapses may be due to the fact that
they could be tested on fewer sections, because they are much
smaller (see above). To test the relative density of NLGN2 in these
synapses and extrasynaptically as well, we measured and
calculated the relative density of the immunogold labeling. The
labeling was specifically enriched in GABAergic and cholinergic
synapses compared to the labeling in extrasynaptic membranes
and type I synapses (for the definition of membrane associated
immunogold particles, please see methods). In three mice, the
linear density of labeling was 12.263.8; 1363.5 and 9.464.7 gold
particles per mm membrane (mean 6 SD) in GABAergic synapses,
whereas it was only 0.1160.1; 0.1260.06 and 0.0660.06 gold
particles per mm at extrasynaptic membrane domains of the same
somata in the vicinity of these synapses. In the same animals, in
cholinergic synapses, the linear density of labeling was 10.566.1;
10.266.2 and 8.265.7 gold particles per mm membrane, whereas
it was only 0.1160.15; 0.160.11 and 0.1360.19 gold particles per
mm at extrasynaptic and type I synaptic membranes of the
postsynaptic targets of cholinergic boutons. The linear density
values of NLGN2 labeling at GABAergic and cholinergic synapses
were compared in three mice and no significant differences were
found (Fig. 2). We identified the postsynaptic targets of cholinergic
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boutons in three mice, and found that at least 48.8%; 68.6% and
48.6% of them innervated pyramidal dendritic shafts (Fig. 1F and
H) and 17.1%; 20%; and 24.3% targeted spines, that also received
a type I input (Fig. 1I). Only 2.9%; 0% and 8.1% of the
cholinergic synapses targeted interneuron dendrites or somata
(three interneuron dendrites and one interneuron soma out of 107
targets), and rarely cholinergic boutons innervated pyramidal cell
somata as well (two out of 107 targets; 0%; 2.9% and 2.7% of the
boutons in three mice). The rest of the postsynaptic targets could
not be unequivocally classified (31.4%; 8.6% and 16.2%).
Occasionally, we found cholinergic boutons that formed two
synapses with different postsynaptic targets (Fig. 1I).
These data show that in the hippocampus virtually all
cholinergic synapses contain NLGN2 at the postsynaptic mem-
brane and its density is just as high in cholinergic as in GABAergic
synapses.
Figure 1. Neuroligin 2 is present postsynaptically at both GABAergic and cholinergic synapses in the hippocampus. Electron
micrographs from combined immunogold/immunoperoxidase experiments for NLGN2 (immunogold: black particles) and ChAT (DAB: dark,
homogenous reaction product) reveal the presence of NLGN2 at ChAT-negative and ChAT-positive type II synapses in the CA1 area. Arrowheads
indicate synapse-edges. A, A pyramidal cell body receives a synapse from a ChAT-negative bouton (bneg) that expresses NLGN2 postsynaptically in a
WT mouse. B, C, In contrast, the same type of immunostaining in a NLGN2-KO mice shows no NLGN2-immunoreactive synapses, demonstrating the
specificity of the antibody. A GABAergic terminal (bneg) from str. pyramidale, lacking gold particles at the postsynaptic site is shown (B). An example
of a synapse of a ChAT-positive bouton (b1) on a dendrite (d) in str. radiatum that is immunonegative for NLGN2 in KO mouse (C). D–I: NLGN2
immunogold labeling is present at the postsynaptic site of synapses established by ChAT-positive axon terminals (b2–5) on dendrites (d) and spines (s)
in str. radiatum (D–G) and oriens (H, I) of WT mice. Serial images show the same synapse in D1 and D2; E1 and E2; F1 and F2; G1 and G2. E1–2
demonstrates that some of the presynaptic profiles were small-diameter, intervaricose-like segments of ChAT-positive axons (b3). In F1–2 and H, the
postsynaptic targets of boutons b4 and b6 are putative pyramidal dendrites (Pd) the latter of which is identified by the presence of spines (s). I,
Occasionally, we found ChAT-positive presynaptic elements that formed synapses with two postsynaptic targets. Here, bouton b7 forms a synapse
with a dendrite and a spine, which receives a type I synapse (black arrowheads). Note, that in many cases, synaptic junctions of ChAT-positive
terminals are atypical (E, F, H, I). Scale bar is 200 nm for all images.
doi:10.1371/journal.pone.0072450.g001
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Neuroligin 2 is also abundant in neocortical cholinergic
synapses
We tested the presence of NLGN2 in the somatosensory (S1)
and prefrontal cortices (PFC) using the same combined immuno-
gold/ immunoperoxidase staining for NLGN2 and ChAT as
above. In the S1 of two WT mouse, 97% and 88.6% of the
cholinergic synapses (n = 33, 35) were identified as NLGN2
positive on the basis of intensified immunogold particles associated
with the postsynaptic membrane (Fig. 3A, B). Cholinergic
terminals formed small type II synapses on dendritic shafts
(60.6% and 60% of all targets; Fig. 3A) and spines (36.4% and
37.1%; Fig. 3B) in the S1, whereas 3% and 2.9% of the
postsynaptic targets remained unidentified. Many of the innervat-
ed dendritic shafts possessed spines on the recorded serial photos
(21.2% and 37.1% of all targets), demonstrating that these
originated presumably from pyramidal cells. In the PFC, almost
all cholinergic synapses collected were NLGN2-positive (92% and
84.8%; n = 25 and 46, two mice; Fig. 3C–E). The morphology and
size of synapses were also similar in these cortical areas: they
formed type II synapses that were usually small. The distribution
of postsynaptic targets were also similar in the S1 and PFC: in the
PFC of two mice 64% and 41.3% of the cholinergic synapses were
found on dendrites (Fig. 3C, D; 20% and 8.7% of all targets were
on putative pyramidal dendrites, because they were spiny on the
serial photos), whereas 24% and 52.2% of the cholinergic inputs
innervated spines (Fig. 3E). Some (12% and 6.5%) of the targets
could not be classified.
Neuroligin 2 is expressed in cholinergic synapses in
several other non-cortical brain areas as well
The basolateral amygdala (BLA), the caudate putamen (CPu)
and the thalamic centrolateral nucleus (CL) receive abundant
cholinergic innervation [46].
In BLA, cholinergic terminals formed type II synapses that were
NLGN2-positive (97.1% and 100%; n = 34 and 47, two mice;
Fig. 4E–G). Cholinergic boutons innervated dendrites (76.5 and
51.1% of all targets in two mice; Fig. 4E–G) and spines (17.6%
and 48.9%; Fig. 4E); 2.9 and 0% of the targets could not be
classified. One of the postsynaptic targets (out of 81) was an
unidentified soma. Large part of the dendritic targets possessed
spines in the examined segment (35.3% and 40.4% of all targets),
suggesting that they originated from pyramidal cells.
In CPu, cholinergic synapses formed type II synapses that were
NLGN2-positive (92% and 97.6% n = 25 and 41, two mice;
Fig. 4A–D). Approximately every second cholinergic synapse
innervated dendrites in CPu (48% and 43.9% of all targets;
Fig. 4A,B and D) whereas the rest of them targeted spines (36%
and 36.6%; Fig. 4C); 16% and 14.6% of all targets remained
unidentified. Out of 66 synapses tested, one targeted a soma and
another targeted an axon initial segment. 36% and 9.8% of all
targets were spiny dendrites, suggesting that they were GABAergic
medium spiny neurons in CPu.
In contrast to other brain areas investigated, cholinergic
synapses formed both type I and type II synapses in CL (53.3%
type I, 30% type II in the first animal; 16% type I, 56% type II in
the second animal; the remaining synapses could not be classified;
n = 30 and 25, two mice). Most cholinergic synapses were
NLGN2-positive in CL (73% and 84%; Fig. 4H, I).
We also tested the NLGN2 content of ChAT-positive synapses
in basal forebrain areas and found that their cholinergic terminals
formed NLGN2-positive type II synapses. The number of positive
samples that were collected are as follows: the medial septum:
n = 14 and 2; vertical limb of diagonal band of Broca: n = 3 and 7;
horizontal limb of diagonal band of Broca: n = 4 and 10;
substantia innominata/ ventral pallidum: n = 9 and 12 synapses
collected from two mice, respectively).
Neuroligin 2 clusters revealed the presence of contact
sites of cholinergic boutons that probably would not
have been considered contact sites previously
In our preliminary experiments, we expected cholinergic
terminals to establish synapses only rarely in cortical areas
[34,35,38,39]. Although cholinergic synapses are known to be
less prominent than GABAergic or glutamatergic synapses, we
expected and searched for typical synapse features. Indeed, several
cholinergic synapses had typical synaptic morphology and
NLGN2 labeling. Based on data in the literature and on our
own experience, NLGN2 is accumulated only in synaptic contact
sites and indeed its clusters appeared in synapses with very typical
morphology. However, it very soon became obvious that not all
cholinergic contact sites resemble typical features of type I or II
synapses. In several cases, we found clusters of NLGN2
immunogold labeling next to ChAT positive terminals, in
membrane appositions that traditionally would not have been
considered synaptic contact sites previously, because of an only
very mild thickening of the membrane and because its size is
smaller than the smallest cortical GABAergic synapses. However,
based on the accumulated data, these contact sites should probably
also be considered synapses.
Especially in the hippocampus and neocortex, a substantial
amount of the cholinergic contact sites possessed hardly detectable
thickening of the synaptic membranes (Fig. 1E, F, H, I; Fig. 3B, E).
Some of these contacts were formed by small-diameter intervar-
icose segments of cholinergic axons (Fig. 1E). In many cases, the
length of parallel appositions between membrane segments of the
presumed pre- and postsynaptic profiles were also small; therefore
probably none of these contact sites could have been recognized
without NLGN2 labeling. However, these contacts were as densely
labeled for NLGN2 as cholinergic synapses that have more
prominent synaptic clefts and postsynaptic densities (Fig. 1.D, 3A,
C). According to our observations, there is a continuum between
clearly apparent synapse-like structures of cholinergic boutons and
Figure 2. Hippocampal cholinergic and GABAergic synapses
express a similar density of neuroligin 2. There was no significant
difference in the density of NLGN2 labeling (intensified gold particles/
mm synaptic membrane) between GABAergic synapses on pyramidal
cell somata (12.263.8, 1363.5 and 9.464.7; mean and standard
deviation in three mice, respectively) and ChAT-positive synapses in
str. radiatum, pyramidale and oriens (10.566.1, 10.266.2 and 8.265.7).
(n.d.: no statistical difference).
doi:10.1371/journal.pone.0072450.g002
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hardly detectable contact sites that can now be recognized based
on the dense NLGN2 labeling.
Cholinergic cells themselves express neuroligin 2 in a
subset of their input synapses
The majority of cholinergic afferents to most of the investigated
brain areas (hippocampus, BLA, S1, PFC) arises from different
parts of the basal forebrain: the medial septum (MS), the vertical
and horizontal limbs of the diagonal band of Broca (VDB and
HDB) and the substantia innominata/ ventral pallidum (SI/VP)
[26]. We tested whether these cholinergic cells of the basal
forebrain express NLGN2 at their input synapses on their
dendrites and/or cell bodies. We found that a subset of their
synaptic inputs were indeed NLGN2-positive (Fig. 5A–E).
NLGN2-positive input synapses of cholinergic cells were collected
in all of the basal forebrain areas investigated (MS: n = 24
dendritic and n = 24 somatic; VDB: n = 29 dendritic and n = 11
somatic, HDB: n = 37 dendritic and n = 14 somatic, SI/VP: n = 50
dendritic and n = 10 somatic synapses from two mice). In the MS,
two of the somatic, and one of the dendritic NLGN2-positive input
synapses were formed by ChAT-positive terminals, while one
similar dendritic input was found in SI/VP, demonstrating that
cholinergic cells can form synaptic connections with each other
and these contacts also contain NLGN2.
In contrast to most of the brain areas that receive their
cholinergic innervation from distant projection neurons, dense
cholinergic innervation in CPu is provided by local cholinergic
interneurons [47]. We found that they also express NLGN2 in a
minority of their input synapses (n = 43 dendritic and n = 7
somatic NLGN2-positive synapses were collected from two mice;
Fig. 5F).
Discussion
The present study provides evidence that besides GABAergic
synapses, cholinergic synapses also express NLGN2 postsynapti-
cally, in all investigated brain areas in mice. Our estimation also
shows that NLGN2 density is similar in cholinergic and
GABAergic synapses in the hippocampus. We identified several
putative contact sites established by cholinergic axons that do not
show the typical morphology of classical synapses and therefore,
Figure 3. Neuroligin 2 is localized postsynaptically at cholinergic synapses in the neocortex. Images demonstrate double
immunohistochemical reactions for ChAT (dark, homogenous DAB precipitate) combined with NLGN2 (black intensified gold particles) in
somatosensory (S1) and prefrontal cortices (PFC). Serial sections of the same synapses are shown in B1–2, D1–2 and E1–2. In both areas, ChAT-positive
boutons (b1–5) form type II synaptic contacts on dendrites (d, A, C, D1–2) and spines (s, B1–2, E1–2) that express NLGN2 at the postsynaptic membranes
(open arrowheads label synaptic edges). The innervated spines also received a type I synapse from a ChAT-negative terminal (B1–2, black arrowheads).
In C the postsynaptic dendrite of bouton b3 receive an additional, type I synaptic input (black arrowheads) from an unlabeled terminal. These type I
synapses in B1–2 and C do not contain NLGN2. In contrast, another ChAT-negative, putative GABAergic bouton (bneg) establishes a type II, NLGN2-
positive synapse (black arrowheads) with a dendrite in D1–2. Scale bar is 200 nm for all images.
doi:10.1371/journal.pone.0072450.g003
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they probably could not be recognized without NLGN2 labeling.
We also found that some of the input synapses of cholinergic cells
contain NLGN2 postsynaptically, demonstrating that cholinergic
cells themselves also express NLGN2.
NLGNs are present postsynaptically and form a trans-synaptic
signal transduction complex with presynaptic neurexins; they
participate in the recruitment of synaptic proteins, and thereby
play an important role in the maturation and activity-dependent
regulation of synaptic contacts [3,4,6,9–11]. Previous immunocy-
tochemical experiments localized NLGN2 exclusively to GABAer-
gic and a small subset of glycinergic synapses [13,14]. Further
investigations and conclusions were based on those results in the
literature and several studies demonstrated that deletion of
NLGN2 caused selective impairment in inhibitory synaptic
transmission [17,22–24], whereas overexpression of NLGN2
resulted in enhanced inhibition [17,19]. However, in the light of
our results, previous conclusions may need to be reconsidered,
because the strength of cholinergic synapses was probably also
altered in NLGN2-KO and NLGN2-overexpressing animals.
Figure 4. Neuroligin 2 is expressed postsynaptically at cholinergic synapses in the caudate putamen, basolateral amygdala and
centrolateral thalamic nucleus. Electron micrographs from combined immunogold/immunoperoxidase experiments show that NLGN2
immunogold labeling (black particles) is present at the postsynaptic site of synapses (open arrowheads) established by ChAT-positive axon terminals
(b1–10, dark reaction product) on dendrites (d) and spines (s) in caudate putamen (CPu, A–D) basolateral amygdala (BLA, E–G), and centrolateral
thalamic nucleus (CL, H–I). Note that many of these boutons form synapses that could hardly be identified without NLGN2 labeling (e.g. b3 in C, b6 in
E or b8 in G). In C, arrow indicates the spine apparatus. In G, a putative GABAergic bouton (bneg) forming a NLGN2-positive type II synapse (black
arrowheads) is also shown next to the ChAT-positive terminal. Serial sections of the same terminal are shown in H1–2. Scale bar is 200 nm for all
images.
doi:10.1371/journal.pone.0072450.g004
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Potential molecular interactions of neuroligin 2 in
cholinergic synapses
In perisomatic GABAergic synapses, NLGN2 was shown to
bind to the GABAA-receptor anchoring protein gephyrin and to
activate collybistin, which is responsible for the membrane
tethering of gephyrin [23]. Through this interaction, NLGN2
participates in the clustering of GABAA receptors at the
postsynaptic side, which likely influences the properties of
GABAergic synapses [23,24,48]. Cholinergic synapses are much
less known than GABAergic ones, however; here, NLGN2 may
also contribute to the recruitment or alignment of synaptic
proteins, including acetylcholine (ACh) receptors in cholinergic
synapses.
What kind of scaffolding proteins can potentially bind to
NLGN2 in cholinergic synapses? The synaptic scaffolding
molecule (S-SCAM; [49]) is also present and interacts with
NLGN2 at inhibitory synapses [50]. Furthermore, it was
demonstrated that in chicken, where only three forms of NLGN
is present (NLGN1,3,4) and NLGN2 is absent [51], S-SCAM is
directly associated with NLGN1 at cholinergic synapses of the
ciliary ganglion [52]. In these synapses, S-SCAM indirectly
interacts with the adenomatous polyposis coli protein that
organizes a multimolecular protein complex which targets a3
nicotinic ACh receptors to the postsynaptic membrane [53,54].
With these interactions NLGN1 might indirectly influence the
strength of these cholinergic contacts. NLGN1 also binds to b-
neurexins in these cholinergic synapses, induces accumulation of
presynaptic components and enhances nicotinic synaptic activity
in chicken ciliary ganglionic cell culture [55]. A third known
binding partner of NLGN1 in cholinergic synapses of the chicken
ciliary ganglion is the scaffolding protein postsynaptic density-93
[52], which is also present in cholinergic synapses of autonomic
ganglia in mouse and plays a role in stabilization of nicotinic
ACh receptors at postsynaptic sites [56]. Although, to the best of
our knowledge, no data is available about the presence of these
three proteins in cholinergic synapses of the mammalian central
nervous system, but our results suggest that they may potentially
be present and interact with NLGN2 in these synapses.
It is known that different NLGN isoforms can be present in the
same synapse. For instance, a subset of GABAergic synapses
express both NLGN 2 and 3; while several glutamatergic synapses
express both NLGN 1 and 3 [15]. Therefore, cholinergic synapses
may also express other types of NLGNs. However, it is not possible
to predict, whether other neuroligin isoforms are also present at
these synapses, because (besides heterodimers [57]) NLGNs can
also form homodimers by themselves.
Possible role of neuroligin 2 in cholinergic synapses
The behavioral phenotype of NLGN2-KO mice and NLGN2-
overexpressing animals has been thoroughly described [19–21,58].
However, the interpretation of these data should be reconsidered
in the light of our new results.
NLGN2-KO mice showed a marked increase in anxiety-like
behavior which can be explained by an impairment in GABAergic
synaptic transmission [20], because pharmacological blockade of
GABAA receptors produces a similar effect [25,59]. In contrast,
positive modulators of GABAergic signaling cause anxiolysis
[25,59,60]. Based on these data, the expected effect of NLGN2
Figure 5. Cholinergic projection neurons of the basal forebrain and neostriatal cholinergic interneurons express NLGN2 in their
inputs synapses. Images from combined immunogold/immunoperoxidase experiments show that dendrites of cholinergic cells (dChAT, dark,
homogenous DAB precipitate) express NLGN2 (intensified gold particles) at postsynaptic membranes of type II synapses (open arrowheads) in the
medial septum (A: MS), vertical- and horizontal diagonal band of Broca (B: VDB; C, D: HDB), substantia innominata/ventral pallidum (E: SI/VP) and
caudate putamen (F: CPu). In B and C two unlabeled dendrites (dneg) also express NLGN2 in their type II synapses (black arrowheads). Scale bar is 200
nm for all images.
doi:10.1371/journal.pone.0072450.g005
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overexpression in GABAergic synapses would be also anxiolytic.
However, global overexpression of NLGN2 resulted in an
enhancement of anxiety-like behavior despite the observed
potentiated GABAergic function [19]. We suggest that these
controversial findings may be explained by a strengthened
cholinergic tone that is due to NLGN2-overexpression, the result
of which may be a subsequent strengthening of these synapses.
This is supported by findings that increased ACh signaling can
indeed induce anxiety-like behavior [61–63]. Nevertheless, it
should also be noted that manipulations of the cholinergic system,
for example nicotine administration, can also induce anxiolytic
effects, depending on treatment type, dose and brain region
investigated [64].
In NLGN2-overexpressing mice, high levels of basal activity,
enhanced startle response, anxiety and stereotyped jumping
behavior was observed [19] that may be the result of an increased
level of arousal. We have detected NLGN2 postsynaptically at
virtually all cholinergic synapses investigated, including those in
the intralaminar thalamus, a brain area that receives cholinergic
innervation from the pedunculopontine nucleus [65]. This
projection is part of the cholinergic arm of the reticular activating
system [65], therefore, if NLGN2 content of these synapses is
increased in NLGN2-overexpressing mice, their arousal state
could also be heightened.
The general effect of NLGN2 manipulation may also depend on
the relative number of cholinergic terminals in different brain
regions. In the hippocampus, according to data published by
different groups, the density of GABAergic terminals seems to be
larger (1.93 x 108 GAD-immunoreactive boutons/mm3 in CA1
area of rat [66]) than the density of cholinergic varicosities (4.9 and
5.6 x 106 ChAT-positive varicosities/mm3 in CA1 area of rat and
mouse, respectively [37]). Since the density of NLGN2 is similar in
cholinergic and GABAergic synapses, but GABAergic synapses are
larger and more numerous, the majority of NLGN2 is localized in
GABAergic synapses in the hippocampus. However, the relative
proportion of cholinergic terminals may outnumber GABAergic
terminals in other brain areas. For instance, in the striatum,
cholinergic terminals are highly abundant (2 x 108 varicosities/
mm3 [36]) and in these areas manipulation of NLGN2 will
probably have a higher impact on the cholinergic system.
Nevertheless, the importance of a molecule at the network level
is not necessarily a linear function of its abundance in the given
brain area.
The incidence of seizure spiking in the frontoparietal EEG of
NLGN2-overexpressing mouse [19] may also be the consequence
of an increased cholinergic tone, because brain oscillations are
under effective cholinergic control [67,68].
Since the cholinergic system influences also brain circuits that
are responsible for regulating motor control, NLGN2 loss in
cholinergic synapses might also contribute to the slightly dimin-
ished motor co-ordination described in NLGN2-KO mice [20,21].
This hypothesis is supported by the observations that gait and
postural instability might be associated with cholinergic dysfunc-
tion in Parkinson’s disease as well [69].
Mutations of NLGN2 gene were recently identified in
schizophrenia patients [18]. Because cholinergic impairments are
implicated in schizophrenia [70], NLGN2 dysfunction in cholin-
ergic synapses may also contribute to the pathophysiology in these
subjects.
Cholinergic and GABAergic cells express neuroligin 2 in
their inputs synapses
We demonstrated that cholinergic neurons of the basal
forebrain and striatum express NLGN2 in the postsynaptic
membrane of their putative GABAergic (ChAT-negative, type
II) and cholinergic (ChAT-positive) inputs synapses. In the
hippocampus, a small fraction of the postsynaptic targets of
NLGN2-positive cholinergic synapses were identified as GABAer-
gic interneurons, which means that GABAergic cells also express
NLGN2.
Neuroligin 2 in non-classical cholinergic contacts
Interestingly, besides classical synapses of cholinergic axons, we
found NLGN2 clusters also at cholinergic contact sites that did
not resemble typical synapses because of their small size and a
very mild thickening of the postsynaptic membrane. Because
NLGN2 is known to recruit other synaptic receptor proteins,
these clusters may label membrane segments that participate in
signal transmission. Therefore, these contacts might be consid-
ered synapses that do not show classical morphology. Many
studies that analyzed the incidence of synaptic contacts formed
by cholinergic boutons concluded that cholinergic innervation of
the brain is mainly non-synaptic [34–36,38,39]. These studies
provided strong support for the volume transmission hypothesis
[71]. In contrast, other groups demonstrated that classical
synaptic contacts predominate among cholinergic inputs
[72,73]. Because we could see a continuum between clearly
synapse-like contacts and those contacts that could be recognized
only with the aid of NLGN2-labeling, the discrepancy between
these groups of studies might be explained by a different
strictness of criteria used in the morphological definition of the
synaptic active zone. Because a completely different approach
would be required, we did not attempt to quantify the proportion
of boutons or inter-bouton (i.e. intervaricose) segments (Fig. 1E)
that formed synaptic contacts in this study. Nevertheless, our
results imply that cholinergic synapses are far more frequent than
presumed previously, even if several of them do not show
classical morphology. This may suggest the importance of
synaptic transmission also in the cholinergic system. Indeed, for
instance, acetylcholinesterase (that terminates the ACh signal) has
a very high catalytic activity [74,75], and it is particularly
abundant in the striatum [76]. These facts suggest that ACh is
quickly cleared from extracellular space; therefore, synaptic
transmission of ACh would be more effective in this area. New
data on phasic ACh release also support this view [75].
Previously, NLGN2 was found in GABAergic and some
glycinergic synapses [13,14], while we found it in cholinergic
synapses in this study. However, information about the possible
presence or absence of NLGN2 in dopaminergic, noradrenergic,
serotonergic and some other types of synapses is still to be
explored.
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